Sugar Cane Ethanol Renewable Energy Service And Technology Company, Industrial Biotechnology Corporation, Announces Web site Launch

Industrial Biotechnology's new site features research and white papers, statistics and pricing data, industry news and links, along with management and partner information.

Industrial Biotechnology Corporation (IBC) , a service and technology products company utilizing renewable sugar cane ethanol as an alternative to petroleum, is pleased to announce the launch of a new corporate Web site at 'http://www.industrialbiotechnology.com'.

Industrial Biotechnology Corporation's newly launched Web site now features renewable energy and sugar cane ethanol research and white papers, statistics and pricing data, industry news and links, management profiles, strategic partner information, company press releases as well as general access for shareholders and institutional and individual investors. The company collaborated with the team at EdgeCore Technologies Corporation in developing the site. For more info visit 'http://www.industrialbiotechnology.com'.

About Industrial Biotechnology Corporation

Industrial Biotechnology Corporation (IBC) provides products, services and technologies using renewable resources as an alternative to petroleum and traditional manufacturing methods. IBC production processes are eco-efficient and apply and adhere to sustainable practices and standards. IBC accomplishes this with the ALCHEMx Production Platforms, which integrates technologies, sustainable manufacturing, and distribution with supply chain partners to meet customer needs and pricing requirements. IBC utilizes sugarcane based feedstock which is considered the leading cost efficient, energy balanced and environmentally sustainable fuel source, when compared to fossil and other alternative fuels. IBC provides cost competitive environmentally responsible solutions to meet global trends and market demand via its operating subsidiaries Renewable Chemicals Corporation and
Renewable Fuels of America Corporation.

Forward-Looking Statements

Certain matters discussed in this press release are "forward-looking statements." These forward-looking statements can generally be identified as such because the context of the statement will include words such as "expects," "should," "believes," "anticipates" or words of similar import. Similarly, statements that describe Industrial Biotechnology Corporation's future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of Industrial Biotechnology Corporation, as appropriate, which could cause actual results to differ materially from those currently anticipated. Although Industrial Biotechnology Corporation believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, it cannot give any assurance that their expectations will be attained. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating any forward-looking statements. Certain factors could cause results and conditions to differ materially from those projected in these forward-looking statements, and some of these factors are discussed below. These factors are not exhaustive. New factors, risks and uncertainties may emerge from time to time that may affect the forward-
looking statements made herein. These forward-looking statements are only made as of the date of this press release and Industrial Biotechnology Corporation does not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Contact:
Craig McClure
Investor Relations
Industrial Biotechnology Corporation
2033 Main Street
Sarasota, FL 34237
941-925-2500 X 3084
ir@industrialbiotechnology.com
HTML: http://www.eworldwire.com/pressreleases/18792
PDF: http://www.eworldwire.com/pdf/18792.pdf
ONLINE NEWSROOM: http://www.eworldwire.com/newsroom/314019.htm
RSS NEWSROOM: http://newsroom.eworldwire.com/xml/newsrooms/314019.xml

   Mr. Craig McClure
   VP Investor & Public Relations
   Industrial Biotechnology Corporation
   Sarasota,    FL,    34237
   USA
   941-363-3084 (phone)
   941-925-2503 (fax)
   ir@industrialbiotechnology.com
   industrialbiotechnology.com